Central serous retinopathy (CSR) is a common ocular disease of young and middle-aged adults that affects men more than women. It manifests as the accumulation of central subretinal fluid (SRF) with or without the presence of retinal pigment epithelial detachment (RPED) and is often associated with reduced visual acuity (VA) or metamorphopsia.1 Most cases of idiopathic CSR resolve spontaneously; however, chronic cases in which the SRF persists longer than 3 months may require treatment.2 In cases of CSR with a focal leak, retinal laser photocoagulation may be an appropriate treatment option to accelerate the resorption of SRF and improve VA.
Central serous retinopathy (CSR) is a common ocular disease of young and middle-aged adults that affects men more than women. It manifests as the accumulation of central subretinal fluid (SRF) with or without the presence of retinal pigment epithelial detachment (RPED) and is often associated with reduced visual acuity (VA) or metamorphopsia.1 Most cases of idiopathic CSR resolve spontaneously; however, chronic cases in which the SRF persists longer than 3 months may require treatment.2 In cases of CSR with a focal leak, retinal laser photocoagulation may be an appropriate treatment option to accelerate the resorption of SRF and improve VA.